Guideline for dialysate (LD) quality of Spanish Society of Nephrology;Guías de gestión de calidad del líquido de diálisis (LD)

Nefrologia

Volumn 24, Issue SUPPL.2, 2004, Pages 1-42

  Perez Garcia R ^a   Gonzalez Parra E ^b   Ceballos, F ^c   Escallada Cotero, R ^d   Gomez Reino M I ^e   Martin Rabadan P ^a   Perez Garcia A ^f   Ramirez Chamond R ^g   Sobrino, P E ^h   Solozabal C ⁱ  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^c Sistemas de tratamiento del agua FMC de España   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e General de Medicamentos de Uso Humano ^*  (Spain)

^f Hosp General U de Valencia   (Spain)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

ⁱ Universidad Pública de Navarra   (Spain)

Author keywords

Concentrate; Dialysate; Endotoxins; Hemodialysis; Water treatment for hemodialysis

Indexed keywords

HEMODIALYSIS FLUID; WATER;

CHEMISTRY; DISINFECTION; DRUG CONTAMINATION; HUMAN; NOMENCLATURE; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; STANDARD;

DISINFECTION; DRUG CONTAMINATION; HEMODIALYSIS SOLUTIONS; HUMANS; QUALITY CONTROL; TERMINOLOGY; WATER;

EID: 16644372223     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Hosokawa S, Oyamaguchi A, Yoshida O: Trace elements and complications in patients undergoing chronic hemodialysis. Nephron 55: 375-379, 1990.
2. Consensus conference: Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Nephrol Dial Transplant 8 (Supl. 1): 1-4, 1993.
3. Barril G, Pérez R, Torres T, Barrio V, Valderrábano F: Acute anemia in a hemodialysis program caused by the appearance of high chloramine levels in the water. Med Clin (Barc) 80: 483-86, 1983.
4. Canaud BJM, Mion CM: Water treatment for contemporary hemodialysis (Chap. 8). En: Replacement of renal function by dialysis, edited by: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF. Netherlands Kluwer ed. pp. 231-255, 1996.
5. Ismail N, Becker BN, Hakim RM: Water treatment for hemodialysis. Am J Nephrol 16: 60-72, 1996.
6. Cannata JB: Aluminium toxicity: its relationship with bone and iron metabolism. Nephrol Dial Transplant 11 (Supl. 3): 69-73, 1996.
7. Villforth JC: FDA safety alert: Chloramine contamination of hemodialysis water supplies. Am J Kid Dis 11: 447, 1988.
8. Botella J, Traver JA, Sanz-Guajardo D, Torres MT, Sanjuan I, Zabala P: Chloramines, an aggravating factor in the anemia of patients on regular dialysis treatment. Proc EDTA 14: 192-199, 1977.
9. Keshaviah P, Luehmann D: The importance of water treatment in haemodialysis and haemofiltration. Proc EDTA ERA 21: 111-131, 1984.
10. Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Agüero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 3: 1002-1007, 1992.
11. Pertosa G, Gesualdo L, Bottalico D, Schena FP: Endotoxins modulate chronically tumour necrosis factor alpha ang interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant 10: 328-333, 1995.
12. Ismail N, Becker BN, Hakim RM: Water treatment for hemodialysis. Am J Nephrol 16: 60-72, 1996.
13. CDC: Morbidity and mortality weekly. March 1980.
14. Comty C, Luehmann D, Wathen R, Shapiro F: Prescription water for chronic hemodialysis. Trans Am Soc Artif Int Organs 10: 189-196, 1974.
15. Johnson WJ, Taves DR: Exposure to excessive fluoride during hemodialysis. Kidney Int 5: 451-454, 1974.
16. Arduino MJ, Bland LA, Favero MS: Adverse patient reactions due to chemical contamination of hemodialysis fluids. Dialysis & Transplantation 18: 655-658, 1989.
17. Pérez García R, Rodríguez Benítez P, Ayala JA: Tratamiento del agua para hemodiálisis. Características del líquido de diálisis. Capítulo 5. En: Tratado de Hemodiálisis. Ed. F. Valderrábano. Edit. Médica Jims SL. Barcelona. 1999. pp. 75-90.
18. Pérez-García R, Anaya F, Chisvert J, Valderrábano F: Association of high-flux dialysers and bacterial contamination of dialysate induced chronic release of cytokines in haemodialysis patients. Nephrol Dial Transplant 11: 2.164-2.166, 1995.
19. Berland Y, Brunet P, Ragon A, Reynier JP: Dialysis fluid and water: their roles in biocompatibility. Nephrol Dial Transplant 10, (Supl. 10): 45-47, 1995.
20. Ureña P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drüeke T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol Dial Transplant 7: 16-28, 1992.
21. Pertosa G, Gesualdo L, Bottalico D, Schena FP: Endotoxins modulate chronically tumour necrosis factor alpha ang interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant 10: 328-333, 1995.
22. Bárány P, Divino JC, Bergström J: High C-Reactive Protein is a strong predictor of resistance to Erythropoietin in Hemodialysis patients. Am J Kid Dis 29: 565-568, 1997.
23. Haverkate F, Thompson SG, Pype SDM, Gallimore JR, Pepys MB: Production of C-reactive protein and risd of coronary events in stable and unstable angina. Lancet 349: 462-466, 1997.
24. Bergström J, Heimbürger O, Lindholm B, Qureshi AR: C-reactive protein as predictor for serum albumin and mortality in hemodialiysis. Gen Am Soc Nephrol 6: 573, 1995.
25. Panichi V, Migliore M, De Pietro S, Metelli MR, Taccola D, Pérez García R, Palla R, Rindi P, Cristofani R, Tetta C: Plasma C-Reactive Protein in Hemodialysis patients: a cross-Sectional, longitudinal clinical survey. Blood Purif 18: 30-36, 2000.
26. Pérez-García R, Rodríguez Benítez P: Why and how to monitor bacterial contamination of dialysate? Nephrol Dial Transplant 15: 760-764, 2000.
27. De Francisco ALM, Pérez García R: Ultrapure dialysate and its effect on patients outcome. Saudi J Kidney Dis Transplant 12 (3): 406-412, 2001.
28. Schiffl H y cols.: NDT 16: 1863, 2001.
29. Lonnemann G: Assessment of the quality of dialysate. Nephrol Dial Transplant 13 (Supl. 5): 17-20, 1998.
30. AAMI Standards for hemodialysis systems: ANSI/AAMI. RD 5. 1981.
31. AAMI Standard and recommended practices: Dialysis. 2001 Edition.
32. Cannata JB: Tratamiento de la intoxicación alumínica: limitaciones de los estudios sobre movilización del aluminio. Nefrología 13 (Supl. 3): 119-122, 1993.
33. Cross J: The development of water treatment technology for hemodialysis. Dial Transplant 26: 596-605, 1997.
34. Pérez-García R, Rodríguez Benítez P: Chloramine, a sneaky contaminant of dialysate. Nephrol Dial Transplant 14: 2579-2582, 1999.
35. Pérez García R, Verde E, Sanz A, Valderrábano F: r-HuEPO Resistance and dialysate chloramine contamination in patients on hemodialysis. Nephron 86: 222-223, 2000.
36. European Pharmacopoea 3rd Edition, Supplement 2001: Monograph 1997: 1167 corrected 2000. Haemodialysis solutions, concentrated, water for diluting. European Pharmacopoea 3rd Edition, Supplement 2001: Monograph 2000: 0128. Solutions for haemodialysis. Real Farmacopea Española. Agua para dilución de disoluciones concentradas para hemodiálisis. Real Farmacopea Española 1167: 375-377, 1997.
37. Real Farmacopea Española. Hemodiálisis, disoluciones para. Real Farmacopea Española 0128: 1064-1067, 1997. Ver índice y referencia en el anexo 6.
38. Fluck S, Mckane W, Cairns T y cols.: Chloramine-indiced haemolysis presenting as erythropoietin resistance. Nephrol Dial Transplant 14: 1687-1691, 1999.
39. Baurmeister U, Vienken J, Daum V: High-flux dialysis membranes: endotoxin transfer by backfiltration can be a problem. Nephrol Dial Transplant 4: 89-93, 1989.
40. Sabbioni E, Pietra R, Ubertalli L y cols.: Salts as a source of metals in dialysis fluids: an assessment study by means of neutron activation analysis. Sci Total Environ 84: 13-23, 1989.
41. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients Nephrol Dial Transplant 13: 552-553, 1998.
42. Keshaviah P, Luehmann D, Shapiro, F y cols.: Investigation of the risks and hazards associated with hemodialysis. (Technical report, Contract #223-78-5046) Silver Spring MD: US. Dept. of Health and Human Services, Public Health Service/ Food and Drug Administration/Bureau of Medical Devices. June 1980.
43. Schindler R, Krautzig S, Lufft V y cols.: Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in vitro dialysis with whole blood. Nephrol Dial Transplant 11: 101-108, 1996.
44. Lonnemann G: Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 43, (Supl. 41): 195-200, 1993.
45. Sundaram S, King AJ, Pereira BJ: Lipopolysaccharide-binding protein and bactericidal /permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes. J Am Soc Nephrol 8: 463-470, 1997.
46. Girndt M, Köhler H, Schiedhelm-Weick E, Schlaak JF, Büschenfelde KHM, Fleischer B: Production of interleukin-6, tumor necrosis factor a and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47: 559-565, 1995.
47. Mion CM, Canaud B, Garred LJ, Stec F, Nguyen QV: Sterile and pyrogen-free bicarbonate dialysate: a necessity for haemodialysis today. Adv Nephrol Necker Hosp 19: 275-314, 1990.
48. Gault MH, Duffett AL, Murphy JF, Purchase LH: In search of sterile, endotoxin-free dialysate. ASAIO J 38: M431-M435, 1992.
49. The EBPG Expert Group on Haemodialysis: European Best Practice Guidelines for Haemodialysis (Part 1). Nephrol Dial Transplant 17 (Supl. 7): Section IV, 45-62, 2002.
50. Arnow PM, Bland LA, García-Houchins S, Fridkin S, Fellner SK: An out break of fatal Fluoride intoxication in a long-term haemodialysis unit. Ann Intern Med 121: 339-344, 1994.
51. Bland LA, Arnow PM, Arduino MJ, Bova I, McAllister SK: Potential hazards of deionization systems used for water purification in haemodialysis. Artif Organs 20: 2-7, 1996.
52. Vanholder R, Vanhaccke E, Ringoir S: Waterborne Pseudomonas septicemia. ASAIO Trans 36: M215-M516, 1990.
53. Gordon SM, Oettinger CW, Bland LA y cols.: Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux haemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 2: 1436-1444, 1992.
54. Wang SA, Levine RB, Carson LA y cols.: An outbreak of Gram-negative bacteremia in haemodialysis patients traced to haemodialysis machine waste drain ports. Infect Control Hosp Epidemiol 20: 746-751, 1999.
55. Vincent FC, Tibi AR, Oarbord JC: A bacterial biofílm in a haemodialysis system. Assessment of disinfection and crossing of endotoxin. ASAIO Trans 35: 310-313, 1989.
56. Man NK, Degremont A, Darbord JC, Collet M, Vaillant P: Evidence of bacterial biofilm in tubing from hydraulic pathway of haemodialysis system. Artif Organs 22: 596-600, 1998.
57. Pass T, Wright R, Sharp B, Harding GB: Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperature underestimate microbial contamination. Blood Purif 14: 136-145, 1996.
58. Carter J: Evaluation of recovery filters for use in bacterial retention testing of sterilizing-grade filters. PDA J Pharm Sci Technol 50: 147-153, 1996.
59. Van der Linde K, Lim BT, Rondeel JM, Antonissen LP, de Jong GM: lmproved bacteriological surveillance of haemodialysis fluids: a comparison between Tryptic soy agar and Reasoner's 2A media. Nephrol Dial Tramplant 14: 2433-2437, 1999.
60. Harada T, Morita T, lwanaga S, Nakamura S, Niwa M: A new chromogenic substrate method for assay of bacterial endotoxins using Limulus hemocyte lysate. Prog Clin Biol Res 29: 209-220, 1979.
61. Mayr HU, Stec F, Mion CM: Standard methods for the microbiological assessment of electrolyte solution prepared on line for haemofiltration. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 454-460, 1985.
62. Kerr PG, Argilés A, Cannaud B, Flavier JL, Mion C: The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic acid on ß-microglobulin removal in hemodiafitration. Am J Kidney Dis 19: 433-438, 1992.
63. Gordon SM, Bland LA, Alexander SR, Newman HF, Arduino MJ, Jarvis WR: Hemolysis associated with hydrogen peroxide at a pediatric dialysis center. Am J Nephrol 10: 123-127, 1990.
64. Arduino MJ: Proper mechanisms for assuring disinfectant concentrations for use in haemodialysis. Nephrol News Issues 13: 18-27, 1999.
65. Lonnemann G, Schindler R: Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate. Clin Nephrol 42 (Supl. 1): s37-s43, 1994.
66. Mittelman MW, Jornitz MW, Meltzer TH: Bacterial cell size and surface charge characteristics relevant to filter validation studies. PDA J Pharm Sci Technol 52: 37-42, 1998.
67. Canaud B, Bosc JY, Leray H, Stec F: Microbiological purity of dialysate for on-line substitution fluid preparation. Nephrol Dial Transplant 15 (Supl. 2): 21-30, 2000.